Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Infect Immun
1997 Jun 01;656:2225-32. doi: 10.1128/iai.65.6.2225-2232.1997.
Show Gene links
Show Anatomy links
Expression of botulinum toxin binding sites in Xenopus oocytes.
Bakry NM
,
Kamata Y
,
Simpson LL
.
???displayArticle.abstract???
The binding of iodinated botulinum toxin type B to nerve membranes was studied by using rat and mouse preparations. The toxin was examined both in the single-chain and in the proteolytically processed dichain form, and binding sites both in the spinal cord and in various brain regions were assayed. Rat and mouse brains possessed specific binding sites for botulinum toxin type B. The average Kd values for the various rat and mouse membrane preparations examined were 4.2 +/- 0.7 nM and 3.7 +/- 0.9 nM, respectively. The average Bmax values for the same tissue preparations were 7.3 +/- 0.7 pmol/mg of protein and 7.5 +/- 1.9 pmol/mg protein, respectively. The binding of botulinum toxin type B to rat brain membranes was not antagonized by a polyclonal antibody against the cytosolic domain of synaptotagmin 1 or by a monoclonal antibody directed against the luminal domain of synaptotagmin 1. In addition, these antibodies did not protect the mouse phrenic nerve-hemidiaphragm from toxin-induced neuromuscular blockade. Extraction of whole-brain mRNA and injection into Xenopus oocytes led to expression of binding sites for botulinum toxin. Extraction and injection of cerebellar mRNA led to expression of a higher density of binding sites. The number of binding sites was not diminished when oocytes were pretreated with antibodies against the cytosolic and luminal domains of synaptotagmin 1. These findings are likely to aid in the isolation, characterization, and reconstitution of toxin binding sites.
BURGEN,
The action of botulinum toxin on the neuro-muscular junction.
1949, Pubmed
BURGEN,
The action of botulinum toxin on the neuro-muscular junction.
1949,
Pubmed
Bakry,
Tetanus toxin and neuronal membranes: the relationship between binding and toxicity.
1991,
Pubmed
Bakry,
Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
1991,
Pubmed
Binz,
Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.
1994,
Pubmed
Black,
Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.
1986,
Pubmed
Black,
Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis.
1986,
Pubmed
Blasi,
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
1993,
Pubmed
Blasi,
Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin.
1993,
Pubmed
Coffield,
The role of transglutaminase in the mechanism of action of tetanus toxin.
1994,
Pubmed
Evans,
Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes.
1986,
Pubmed
Habermann,
Clostridial neurotoxins: handling and action at the cellular and molecular level.
1986,
Pubmed
Kozaki,
Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain.
1979,
Pubmed
Montecucco,
Mechanism of action of tetanus and botulinum neurotoxins.
1994,
Pubmed
Mundigl,
A radioimmunoassay to monitor synaptic activity in hippocampal neurons in vitro.
1995,
Pubmed
Nishiki,
Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes.
1994,
Pubmed
Nishiki,
The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a.
1996,
Pubmed
Nishiki,
Solubilization and characterization of the acceptor for Clostridium botulinum type B neurotoxin from rat brain synaptic membranes.
1993,
Pubmed
Patarnello,
Neurotransmission and secretion.
1993,
Pubmed
Sakaguchi,
Clostridium botulinum toxins.
1982,
Pubmed
Schiavo,
Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds.
1993,
Pubmed
Schiavo,
Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.
1992,
Pubmed
Schiavo,
Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin.
1993,
Pubmed
Schiavo,
Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.
1993,
Pubmed
Schiavo,
Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus.
1994,
Pubmed
Simpson,
Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
1983,
Pubmed
Simpson,
Isolation and characterization of the Botulinum neurotoxins.
1988,
Pubmed
Williams,
Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes.
1983,
Pubmed
Yamasaki,
Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin.
1994,
Pubmed
Yamasaki,
Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2.
1994,
Pubmed
Yokosawa,
Binding of botulinum type Cl, D and E neurotoxins to neuronal cell lines and synaptosomes.
1991,
Pubmed
